FdaApplication
ANDA 208942
Identifiers
- fda_app_no: ANDA208942
Properties
| Property | Value |
|---|---|
| applicant_name | RISING PHARMA HOLDING INC |
| application_type | ANDA |
| approval_date | 2021-01-21 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DOXYCYCLINE | DOXYCYCLINE | EQ 75MG BASE | CAPSULE;ORAL |
| DOXYCYCLINE | DOXYCYCLINE | EQ 100MG BASE | CAPSULE;ORAL |
| DOXYCYCLINE | DOXYCYCLINE | EQ 50MG BASE | CAPSULE;ORAL |
3 products